Cited by 131Diabetes Treatment and ManagementDiabetes Management and ResearchDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.

Glycemic Variation and Cardiovascular Risk in the Veterans Affairs Diabetes Trial

Open access

Zhou, Jin J., Schwenke, Dawn C., Bahn, Gideon, Reaven, Peter·2018·Diabetes Care

DOI 10.2337/dc18-0548PMC PMC6150432

Open this paper in CoChat — free account Open PDF

Abstract

OBJECTIVE: There is uncertainty about the importance of glycemic variability in cardiovascular complications in patients with type 2 diabetes. Using the Veterans Affairs Diabetes Trial (VADT), we investigated the association between variation in fasting glucose and glycated hemoglobin (HbA1c) over time and the incidence of cardiovascular disease (CVD) and assessed whether this is influenced by intensive or standard glycemic control. RESEARCH DESIGN AND METHODS: During the VADT, fasting glucose and HbA1c were measured every 3 months for up to 84 months in 1,791 individuals. Variability measures included coefficient of variation (CV) and average real variability (ARV) for fasting glucose and HbA1c. Overall mean glucose and HbA1c measures as well as their maximum and the most recent measurement were also examined. RESULTS: Variability measures (CV and ARV) of fasting glucose were significantly associated with CVD even after adjusting for other risk factors, including mean fasting glucose. When considering separately groups receiving intensive and standard glycemic control, this relationship was evident in the intensive treatment group but not in the standard group. Additional adjustment for severe hypoglycemic episodes did not alter the relationship between fasting glucose variability and CVD. Interestingly, no HbA1c measures were associated with CVD after adjusting for multiple baseline risk factors. CONCLUSIONS: Our analysis indicates that in the VADT, variability of fasting glucose plays a role in the development of CVD complications beyond the influence of standard fasting glucose measures. The adverse consequences of fasting glucose variability on CVD appear greatest in those receiving intensive glucose control.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.2337/dc18-0548

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
(1998) · The Lancet · doi:10.1016/s0140-6736(98)07019-6 · Cited by 20,023
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Self-citation
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial
Dormandy, J. A., Charbonnel, B., Eckland, D. J., Erdmann, E., Massi-Benedetti, M., Moules, I. K., Skene, A. M., Tan, M. H., Lefèbvre, P. J., Murray, G. D., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67528-9 · Cited by 4,129
Dietary Advanced Glycation End Products and Their Potential Role in Cardiometabolic Disease in Children
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,023
Severe hypoglycemia and risks of vascular events and death
Zoungas, S., Patel, A., Chalmers, J., de Galan, B. E., Li, Q., Billot, L., Woodward, M., Ninomiya, T., Neal, B., MacMahon, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003795 · Cited by 1,471

Flagged first, then by citations

Show all 37 references

Sorted by citations

Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175
Heart Disease and Stroke Statistics—2021 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Aparicio, H. J., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Cheng, S., Delling, F. N., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000950 · Cited by 5,784
2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz486 · Cited by 4,763
Glycemic variability: adverse clinical outcomes and how to improve it?
Zhou, Z. G., Sun, B., Huang, S., Zhu, C., & Bian, M. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01085-6 · Cited by 273
Comprehensive elaboration of glycemic variability in diabetic macrovascular and microvascular complications
Sun, B., Luo, Z., & Zhou, J. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01200-7 · Cited by 168
Self-citation
Variability of risk factors and diabetes complications
Ceriello, A., & Prattichizzo, F. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01289-4 · Cited by 186
Visit-to-Visit Glycemic Variability and Risks of Cardiovascular Events and All-Cause Mortality: The ALLHAT Study
Echouffo-Tcheugui, J. B., Zhao, S., Brock, G. N., Matsouaka, R., Kline, D., & Joseph, J. J. (2019) · Diabetes Care · doi:10.2337/dc18-1430 · Cited by 162
Glycemic variability and cardiovascular disease in patients with type 2 diabetes
Martinez, M., Santamarina, J., Pavesi, A., Musso, C., & Umpierrez, G. E. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-002032 · Cited by 155
Visit-to-Visit HbA1c Variability Is Associated With Cardiovascular Disease and Microvascular Complications in Patients With Newly Diagnosed Type 2 Diabetes
Li, S., Németh, I., Donnelly, L. A., Hapca, S. M., Zhou, K., & Pearson, E. R. (2019) · Diabetes Care · doi:10.2337/dc19-0823 · Cited by 144
Glycaemic management in diabetes: old and new approaches
Ceriello, A., Prattichizzo, F., Phillip, M., Hirsch, I. B., Mathieu, C., & Battelino, T. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00245-x · Cited by 149
Glucose Variability: How Does It Work?
Klimontov, V. V., Saik, O., & Korbut, A. I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157783 · Cited by 133
Comparison of the Effects of Fasting Glucose, Hemoglobin A1c, and Triglyceride–Glucose Index on Cardiovascular Events in Type 2 Diabetes Mellitus
Su, W., Chen, S., Huang, Y.-T., Huang, J., Wu, P.-Y., Hsu, W., & Lee, M. (2019) · Nutrients · doi:10.3390/nu11112838 · Cited by 113
Prognostic Significance of Long-term HbA1c Variability for All-Cause Mortality in the ACCORD Trial
Sheng, C., Tian, J., Miao, Y., Cheng, Y., Yang, Y., Reaven, P. D., Bloomgarden, Z. T., & Ning, G. (2020) · Diabetes Care · doi:10.2337/dc19-2589 · Cited by 114
Self-citation
Long-term HbA1c variability and macro-/micro-vascular complications in type 2 diabetes mellitus: a meta-analysis update
Sartore, G., Ragazzi, E., Caprino, R., & Lapolla, A. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02037-8 · Cited by 106
Glycemic Variability and CNS Inflammation: Reviewing the Connection
Watt, C., RANGEL, E. S., & Hwang, J. J. (2020) · Nutrients · doi:10.3390/nu12123906 · Cited by 89
HbA1c variability predicts cardiovascular complications in type 2 diabetes regardless of being at glycemic target
Ceriello, A., Lucisano, G., Prattichizzo, F., Grotta, R. L., Franzén, S., Svensson, A., Eliasson, B., & Nicolucci, A. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01445-4 · Cited by 78
Long-term glycemic variability and vascular complications in type 2 diabetes: post hoc analysis of the field study
Scott, E. S., Januszewski, A. S., O’Connell, R., Fulcher, G., Scott, R., Kesaniemi, A., Wu, L., Colagiuri, S., Keech, A., & Jenkins, A. J. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa361 · Cited by 70
Association of Long-term Change and Variability in Glycemia With Risk of Incident Heart Failure Among Patients With Type 2 Diabetes: A Secondary Analysis of the ACCORD Trial
Segar, M. W., Patel, K. V., Vaduganathan, M., Caughey, M. C., Butler, J., Fonarow, G. C., Grodin, J. L., McGuire, D. K., & Pandey, A. (2020) · Diabetes Care · doi:10.2337/dc19-2541 · Cited by 70
Glucose variability: a new risk factor for cardiovascular disease
Belli, M., Bellia, A., Sergi, D., Barone, L., Lauro, D., & Barillà, F. (2023) · Acta Diabetologica · doi:10.1007/s00592-023-02097-w · Cited by 68
Glucose Variability and Diabetic Complications: Is It Time to Treat?
Ceriello, A. (2020) · Diabetes Care · doi:10.2337/dci20-0012 · Cited by 59
Glycemic control, HbA1c variability, and major cardiovascular adverse outcomes in type 2 diabetes patients with elevated cardiovascular risk: insights from the ACCORD study
Pei, J., Wang, X., Pei, Z., & Hu, X. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-02026-9 · Cited by 59
Association between visit-to-visit variability of HbA1c and cognitive decline: a pooled analysis of two prospective population-based cohorts
Yu, Z., Zhu, Y., Li, D., Wu, M., Tang, M., Wang, J., & Chen, K. (2019) · Diabetologia · doi:10.1007/s00125-019-04986-8 · Cited by 58
Glucose variability and the risks of stroke, myocardial infarction, and all-cause mortality in individuals with diabetes: retrospective cohort study
Lee, D. Y., Han, K., Park, S. H., Yu, J. H., Seo, J. A., Kim, N. H., Yoo, H. J., Kim, S. G., Choi, K. M., Baik, S. H., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01134-0 · Cited by 58
Correlation Between Glycemic Variability and Diabetic Complications: A Narrative Review
Huang, L., Pan, Y., Zhou, K., Liu, H., & Zhong, S. (2023) · International Journal of General Medicine · doi:10.2147/ijgm.s418520 · Cited by 54
Particularities of Urinary Tract Infections in Diabetic Patients: A Concise Review
Confederat, L. G., Condurache, I., Alexa, R.-E., & Dragostin, O.-M. (2023) · Medicina · doi:10.3390/medicina59101747 · Cited by 62
Insulin-Induced Skin Lipohypertrophy in Type 2 Diabetes: a Multicenter Regional Survey in Southern Italy
Gentile, S., Guarino, G., Corte, T. D., Marino, G., Fusco, A., Corigliano, G., Colarusso, S., Piscopo, M., Improta, M. R., Corigliano, M., et al. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00876-0 · Cited by 50
GWAS of longitudinal trajectories at biobank scale
Ko, S., German, C., Jensen, A. E., Shen, J., Wang, A., Mehrotra, D. V., Sun, Y. V., Sinsheimer, J. S., Zhou, H., & Zhou, J. J. (2022) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2022.01.018 · Cited by 41
Self-citation
Visit-to-visit variability of glycemia and vascular complications: the Hoorn Diabetes Care System cohort
Slieker, R. C., van der Heijden, A. A. W. A., Nijpels, G., Elders, P. J. M., Hart, L. M. ‘., & Beulens, J. W. J. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0975-1 · Cited by 44
Empagliflozin reduced long-term HbA1c variability and cardiovascular death: insights from the EMPA-REG OUTCOME trial
Ceriello, A., Ofstad, A. P., Zwiener, I., Kaspers, S., George, J. T., & Nicolucci, A. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01147-9 · Cited by 45
Impact of post-procedural glycemic variability on cardiovascular morbidity and mortality after transcatheter aortic valve implantation: a post hoc cohort analysis
Besch, G., Pili‐Floury, S., Morel, C., Gilard, M., Flicoteaux, G., du Mont, L. S., Perrotti, A., Meneveau, N. F., Chocron, S., Schiele, F., et al. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0831-3 · Cited by 43
Long-term variability of glycemic markers and risk of all-cause mortality in type 2 diabetes: the Look AHEAD study
Kaze, A. D., Santhanam, P., Erqou, S., Ahima, R. S., & Echouffo-Tcheugui, J. B. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001753 · Cited by 40
Significance of Glycemic Variability in Diabetes Mellitus
Kusunoki, Y., Konishi, K., Tsunoda, T., & Koyama, H. (2022) · Internal Medicine · doi:10.2169/internalmedicine.8424-21 · Cited by 40
Glycemic Trajectories and Treatment Outcomes of Patients with Newly Diagnosed Tuberculosis: A Prospective Study in Eastern China
Liu, Q., You, N., Pan, H., Shen, Y., Lü, P., Wang, J., Lu, W., Zhu, L., & Martínez, L. (2021) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202007-2634oc · Cited by 42
Fasting glucose variability in young adulthood and incident diabetes, cardiovascular disease and all-cause mortality
Bancks, M. P., Carson, A. P., Lewis, C. E., Gunderson, E. P., Reis, J. P., Schreiner, P. J., Yano, Y., & Carnethon, M. R. (2019) · Diabetologia · doi:10.1007/s00125-019-4901-6 · Cited by 36
Liver enzyme variability and risk of heart disease and mortality: A nationwide population‐based study
Cho, E. J., Han, K., Lee, S., Shin, D. W., & Yu, S. J. (2020) · Liver International · doi:10.1111/liv.14432 · Cited by 35
Pharmacological management of vascular endothelial dysfunction in diabetes: TCM and western medicine compared based on biomarkers and biochemical parameters
Oduro, P. K., Fang, J., Niu, L., Li, Y., Li, L., Zhao, X., & Wang, Q. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104893 · Cited by 31
Heterogeneous treatment effects of intensive glycemic control on major adverse cardiovascular events in the ACCORD and VADT trials: a machine-learning analysis
Edward, J. A., Josey, K., Bahn, G., Caplan, L., Reusch, J. E. B., Reaven, P. D., Ghosh, D., & Raghavan, S. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01496-7 · Cited by 32
Self-citation
Endothelial Dysfunction and Platelet Hyperactivation in Diabetic Complications Induced by Glycemic Variability
Huang, Y., Yue, L., Qiu, J., Gao, M., Liu, S., & Wang, J. (2022) · Hormone and Metabolic Research · doi:10.1055/a-1880-0978 · Cited by 31
Glucocentric risk factors for macrovascular complications in diabetes: Glucose ‘legacy’ and ‘variability’-what we see, know and try to comprehend
Monnier, L., Colette, C., Schlienger, J.-L., Bauduceau, B., & Owens, D. R. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.01.007 · Cited by 29
Review of the veteran affairs diabetes trial: Lessons learned
Tran, K., & Reaven, P. D. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09558-5 · Cited by 27
Self-citation
Association of Longitudinal Values of Glycated Hemoglobin With Cardiovascular Events in Patients With Type 2 Diabetes and Multivessel Coronary Artery Disease
Rezende, P. C., Hlatky, M. A., Hueb, W. A., Garcia, R. M. R., Selistre, L. D. S., Lima, E. G., Garzillo, C. L., Scudeler, T. L., Boros, G. A. B., Ribas, F. F., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.19666 · Cited by 28
Impact of long-term glucose variability on coronary atherosclerosis progression in patients with type 2 diabetes: a 2.3 year follow-up study
Li, S., Tang, X., Luo, Y., Wu, B., Huang, Z., Li, Z., Peng, L., Ling, Y., Zhu, J., Zhong, J., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01126-0 · Cited by 27
Glycaemic variation is a predictor of all-cause mortality in the Veteran Affairs Diabetes Trial
Zhou, J. J., Koška, J., Bahn, G., & Reaven, P. D. (2019) · Diabetes and Vascular Disease Research · doi:10.1177/1479164119827598 · Cited by 27
Self-citation
Visit-to-visit fasting plasma glucose variability is associated with left ventricular adverse remodeling in diabetic patients with STEMI
Yang, C. D., Shen, Y. H., Ding, F. H., YANG, Z. K., Hu, J., Shen, W. F., Zhang, R., Lu, L., & Wang, X. Q. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01112-6 · Cited by 27
Long-term glucose variability and incident cardiovascular diseases and all-cause mortality events in subjects with and without diabetes: Tehran Lipid and Glucose Study
Barzegar, N., Ramezankhani, A., Tohidi, M., Azizi, F., & Hadaegh, F. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108942 · Cited by 27
Association between Variability of Metabolic Risk Factors and Cardiometabolic Outcomes
Park, M., & Choi, K. M. (2022) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0316 · Cited by 25
FHL3 promotes the formation of fast glycolytic muscle fibers by interacting with YY1 and muscle glycolytic metabolism
Bai, W., Zhang, Y., Ma, J., Du, M., Xu, H., Wang, J., Zhang, L., Li, W., Hou, Y., Liu, X., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04680-w · Cited by 26
Fasting Glucose Variation Predicts Microvascular Risk in ACCORD and VADT
Zhou, J. J., Koška, J., Bahn, G., & Reaven, P. D. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa941 · Cited by 24
Self-citation
Visit-to-visit fasting blood glucose variability and lifetime risk of cardiovascular disease: a prospective study
Bi, J., Song, L., Wang, L., Wu, M., Chen, S., Wang, Y., Wu, S., & Tian, Y. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01397-1 · Cited by 25
Person‐Centered Primary Care and Type 2 Diabetes: Beyond Blood Glucose Control
Trout, K. K., McCool, W. F., & Homko, C. J. (2019) · Journal of Midwifery & Women s Health · doi:10.1111/jmwh.12973 · Cited by 34
Insulin-Related Lipohypertrophy in Hemodialyzed Diabetic People: a Multicenter Observational Study and a Methodological Approach
Gentile, S., Strollo, F., Satta, E., Corte, T. D., Romano, C., & Guarino, G. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-0650-2 · Cited by 23
New Insights into the Role of Visit-to-Visit Glycemic Variability and Blood Pressure Variability in Cardiovascular Disease Risk
Zhou, J. J., Nuyujukian, D. S., & Reaven, P. D. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01454-x · Cited by 21
Self-citation
Cardiovascular Risk/Disease in Type 2 Diabetes Mellitus
Román, G., & Stoian, A. P. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.97422 · Cited by 26
Association Between Fasting Glucose Variability in Young Adulthood and the Progression of Coronary Artery Calcification in Middle Age
Feng, W., Li, Z., Guo, W., Fan, X., Zhou, F., Zhang, K., Ou, C., Huang, F., & Chen, M. (2020) · Diabetes Care · doi:10.2337/dc20-0838 · Cited by 19
Lipohypertrophy in Elderly Insulin-Treated Patients With Type 2 Diabetes
the AMD-OSDI Study Group on Injection Techniques, Gentile, S., Guarino, G., Corte, T. D., Marino, G., Fusco, A., Corigliano, G., Colarusso, S., Piscopo, M., Improta, M. R., et al. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00954-3 · Cited by 21
Extrinsic and intrinsic factors influencing metabolic memory in type 2 diabetes
Vasishta, S., Umakanth, S., Adiga, P. K., & Joshi, M. B. (2021) · Vascular Pharmacology · doi:10.1016/j.vph.2021.106933 · Cited by 21
Association of low fasting C-peptide levels with cardiovascular risk, visit-to-visit glucose variation and severe hypoglycemia in the Veterans Affairs Diabetes Trial (VADT)
Koška, J., Nuyujukian, D. S., Bahn, G., Zhou, J. J., & Reaven, P. D. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01418-z · Cited by 19
Self-citation
Efficacy of Bolus Calculation and Advanced Carbohydrate Counting in Type 2 Diabetes: A Randomized Clinical Trial
Christensen, M. B., Serifovski, N., Herz, A. M. H., Schmidt, S., Hommel, E. E., RAIMOND, L. H., Perrild, H., Gotfredsen, A., Gæde, P., & Nørgaard, K. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0276 · Cited by 20
Protection of diabetes in aortic abdominal aneurysm: Are antidiabetics the real effectors?
Picatoste, B., Cerro-Pardo, I., Blanco‐Colio, L. M., & Martı́n-Ventura, J. L. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1112430 · Cited by 16
Association between glucose variation and lower extremity amputation incidence in individuals with type 2 diabetes: a nationwide retrospective cohort study
Li, C.-I., Cheng, H.-M., Liu, C.-S., Lin, C., Lin, W.-Y., Wang, M.-C., Yang, S.-Y., Lin, C., & Lin, C. (2019) · Diabetologia · doi:10.1007/s00125-019-05012-7 · Cited by 15
Age- and sex-specific profiles of temporal fasting plasma glucose variability in a population undergoing routine health screening
Lartey, A. H., Li, X., Li, Z., Zhang, Q., & Wang, J. (2021) · BMC Public Health · doi:10.1186/s12889-021-10367-x · Cited by 15
Refining determinants of associations of visit-to-visit blood pressure variability with cardiovascular risk: results from the Action to Control Cardiovascular Risk in Diabetes Trial
Nuyujukian, D. S., Zhou, J. J., Koska, J., & Reaven, P. D. (2021) · Journal of Hypertension · doi:10.1097/hjh.0000000000002931 · Cited by 14
Self-citation
Effect of mean HbA1c on the association of HbA1c variability and all‐cause mortality in patients with type 2 diabetes
Tseng, J., Chen, H., Huang, K., Hsu, S.-P., & Chen, C. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13951 · Cited by 13
Type 2 diabetes remission trajectories and variation in risk of diabetes complications: A population-based cohort study
Dambha-Miller, H., Hounkpatin, H. O., Stuart, B., Farmer, A., & Griffin, S. (2023) · PLOS ONE · doi:10.1371/journal.pone.0290791 · Cited by 13
Association of Glycemic Variability With Imaging Markers of Vascular Burden, β-Amyloid, Brain Atrophy, and Cognitive Impairment
Jang, H., Lee, S., An, S., Park, Y., Kim, S.-J., Cheon, B. K., Kim, J. H., Kim, H. J., Na, D. L., Kim, J. P., et al. (2023) · Neurology · doi:10.1212/wnl.0000000000207806 · Cited by 14
WiSER: Robust and scalable estimation and inference of within‐subject variances from intensive longitudinal data
German, C., Sinsheimer, J. S., Zhou, J. J., & Zhou, H. (2021) · Biometrics · doi:10.1111/biom.13506 · Cited by 15
Self-citation
Visit-to-Visit Glucose Variability, Cognition, and Global Cognitive Decline: The Multi-Ethnic Study of Atherosclerosis
Schaich, C. L., Bancks, M. P., Hayden, K. M., Ding, J., Rapp, S. R., Bertoni, A. G., Heckbert, S. R., Hughes, T. M., & Mongraw‐Chaffin, M. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad444 · Cited by 12
Longitudinal changes in fasting plasma glucose are associated with risk of cancer mortality: A Chinese cohort study
Wu, M., Lu, J., Yang, Z., Shen, P., Yu, Z., Tang, M., Jin, M., Lin, H., Chen, K., & Wang, J. (2021) · Cancer Medicine · doi:10.1002/cam4.4070 · Cited by 11
Intensive Glucose Control and Type 2 Diabetes — 15 Years On
Reaven, P. D., Hayward, R. A., & Zhou, J. J. (2019) · New England Journal of Medicine · doi:10.1056/nejmc1909041 · Cited by 11
Self-citation
Age and sex-specific associations of visit-to-visit variability of glycated hemoglobin A1c with all-cause mortality in patients with diabetes
Yeh, S., Ooi, S.-W., Chang, Y., Li, C., & Chen, H.-F. (2022) · Medicine · doi:10.1097/md.0000000000029942 · Cited by 10
Glycated haemoglobin variability and risk of renal function decline in type 2 diabetes mellitus: An updated systematic review and meta‐analysis
Wang, S., Song, S., Gao, J., Duo, Y., Gao, Y., Fu, Y., Dong, Y., Yuan, T., & Zhao, W. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15861 · Cited by 15
Evaluation of Effects of Continuous Glucose Monitoring on Physical Activity Habits and Blood Lipid Levels in Persons With Type 1 Diabetes Managed With Multiple Daily Insulin Injections: An Analysis Based on the GOLD Randomized Trial (GOLD 8)
Nyström, T., Schwarz, E., Dahlqvist, S., Wijkman, M. O., Ekelund, M., Holmer, H., Bolinder, J., Hellman, J., Imberg, H., Hirsch, I. B., et al. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221101916 · Cited by 10
Epigenetics in the Development of Diabetic Cardiomyopathy
Pepin, M. E., & Wende, A. R. (2019) · Epigenomics · doi:10.2217/epi-2019-0027 · Cited by 10
Implications of fasting plasma glucose variability on the risk of incident peripheral artery disease in a population without diabetes: a nationwide population-based cohort study
Chung, H. S., Hwang, S. Y., Kim, J. A., Roh, E., Yoo, H. J., Baik, S. H., Kim, N. H., Seo, J. A., Kim, S. G., Kim, N. H., et al. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01448-1 · Cited by 11
Visit-to-Visit Variability in Fasting Blood Glucose Predicts the New-Onset Heart Failure: Results From Two Large Chinese Cohorts
Wang, Y., Zhou, J., Qi, W., Zhang, N., Tse, G., Li, G., Wu, S., & Liu, T. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.101842 · Cited by 10
Self-citation
Visit to Visit Hemoglobin A1c Variation and Long-term Risk of Major Adverse Limb Events in Patients With Type 2 Diabetes
Hsiao, F., Chan, Y., Tung, Y., Lin, C., Lee, T., Wang, Y.-C., & Chu, P. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad203 · Cited by 8
Comparison of 10 × 1-minute high-intensity interval training (HIIT) versus 4 × 4-minute HIIT on glucose control and variability in females with type 2 diabetes
Marcotte‐Chénard, A., Tremblay, R., Deslauriers, L., Geraldes, P., Gayda, M., Christou, D., Mampuya, W. M., Little, J. P., & Riesco, É. (2023) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2023-0326 · Cited by 9
Visit-to-visit HbA1c variability is associated with poor prognosis in peritoneal dialysis patients with type 2 diabetes mellitus
Zhang, F., Shi, T., Feng, X., Shi, Y., Zhang, G., Liu, Y., & Fu, P. (2023) · BMC Nephrology · doi:10.1186/s12882-023-03348-2 · Cited by 8
High dose cholecalciferol supplementation causing morning blood pressure reduction in patients with type 1 diabetes mellitus and cardiovascular autonomic neuropathy
Felício, J. S., de Moraes, L. V., Lemos, G., de Souza, Í. J. A., Vieira, G. C., Silva, L. D. S. D., de Queiroz, N. N. M., Souza, A. C., de Melo, F. T. C., Neto, J. F. A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-56934-1 · Cited by 10
Effects of long-term HbA1c variability on serious infection risks in patients with type 2 diabetes and the influence of age, sex and ethnicity: A cohort study of primary care data
Carey, I. M., Critchley, J., Chaudhry, U. A. R., Cook, D. G., DeWilde, S., Limb, E. S., Bowen, L., Woolford, S. J., Whincup, P. H., Sattar, N. A., et al. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111641 · Cited by 8
Fasting Glucose Variability as a Risk Indicator for End-Stage Kidney Disease in Patients with Diabetes: A Nationwide Population-Based Study
Lee, D. Y., Kim, J., Park, S. H., Park, S. Y., Yu, J. H., Seo, J. A., Kim, N. H., Yoo, H. J., Kim, S. G., Choi, K. M., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10245948 · Cited by 8
Association of visit-to-visit HbA1c variability with cardiovascular diseases in type 2 diabetes within or outside the target range of HbA1c
Sun, B., Gao, Y., He, F., Liu, Z., Zhou, J., Wang, X., & Zhang, W. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1052485 · Cited by 8
Self-citation
A platform for phenotyping disease progression and associated longitudinal risk factors in large-scale EHRs, with application to incident diabetes complications in the UK Biobank
Kim, D. H., Jensen, A. E., Jones, K., Raghavan, S., Phillips, L. S., Hung, A. M., Sun, Y. V., Li, G., Reaven, P. D., Zhou, H., et al. (2023) · JAMIA Open · doi:10.1093/jamiaopen/ooad006 · Cited by 6
Self-citation
“Hyperglycemic Memory”: Observational Evidence to Experimental Inference
Ahmadi, M., Ghafouri‐Fard, S., Najari-Hanjani, P., Morshedzadeh, F., Malakoutian, T., Abbasi, M., Akbari, H., Amoli, M. M., & Saffarzadeh, N. (2024) · Current Diabetes Reviews · doi:10.2174/0115733998279869231227091944 · Cited by 6
2. Glycaemic control assessment and targets in type 2 diabetes
Colagiuri, S., & Ceriello, A. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112146 · Cited by 7
Association between continuous glucose monitoring-derived metrics and coronary plaque vulnerability: A retrospective exploratory analysis
Sugimoto, H., Hironaka, K., Yamada, T., Otowa‐Suematsu, N., Hirota, Y., Otake, H., Hirata, K., Sakaguchi, K., Ogawa, W., & Kuroda, S. (2025) · eLife · doi:10.7554/elife.102860 · Cited by 5
Low Blood Glucose Index Associated with Cardiovascular Events in Diabetic Hemodialysis Patients
He, R., Xuan, Y., Zhu, L., Pang, S., Qin, L., Tian, J., & Yuan, J. (2023) · Blood Purification · doi:10.1159/000531964 · Cited by 5
Triglyceride-glucose index variability and risk of all-cause and cardiovascular mortality
Park, J., Kim, D. H., & Lee, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-21324-8 · Cited by 6
Serum 25-hydroxyvitamin D level is associated with short-term glycemic variability metrics derived from continuous glucose monitoring in T2DM
Zhao, G., Yu, X., Wang, L., Jin, Y., Yang, A., Sun, F., Wang, X., Jing, X., & Gao, B. (2023) · Scientific Reports · doi:10.1038/s41598-023-45846-1 · Cited by 4
Insulin-induced skin lipohypertrophies: A neglected cause of hypoglycemia in dialysed individuals with diabetes
Gentile, S., Satta, E., Strollo, F., Guarino, G., Romano, C., Corte, T. D., & Alfarone, C. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.05.018 · Cited by 4
Baseline blood pressure modifies the role of blood pressure variability in mortality: Results from the ACCORD trial
Nuyujukian, D. S., Newell, M., Zhou, J. J., Koška, J., & Reaven, P. D. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14649 · Cited by 4
Self-citation
Long-term glycemic variability predicts compromised development of heart failure with improved ejection fraction: a cohort study
Yang, C. D., Chen, J. W., Quan, J. W., Shu, X. Y., Feng, S., Aihemaiti, M., Ding, F. H., Shen, W. F., Lu, L., Zhang, R., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1211954 · Cited by 4
Associations of metabolic variabilities and cardiovascular outcomes according to estimated glomerular filtration rate in chronic kidney disease: a nationwide observational cohort study
Cho, J. M., Han, K., Joo, K. W., Lee, S., Kim, Y., Cho, S., Huh, H., Kim, S. G., Kim, M., Kang, E., et al. (2024) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.23.135 · Cited by 4
Employing an Artificial Intelligence Platform to Enhance Treatment Responses to GLP-1 Agonists by Utilizing Metabolic Variability Signatures Based on the Constrained Disorder Principle
Landau, J., Tiram, Y., & Ilan, Y. (2025) · Biomedicines · doi:10.3390/biomedicines13112645 · Cited by 4
A study of factors influencing long-term glycemic variability in patients with type 2 diabetes: a structural equation modeling approach
Gan, Y., Chen, M., Kong, L., Wu, J., Pu, Y. D., Wang, X., Zhou, J., Fan, X., Xiong, Z., & Qi, H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1216897 · Cited by 4
Self-citation
Interplay of glycated hemoglobin and traditional risk factors for the risk of atherosclerotic cardiovascular disease and all-cause mortality in people without diabetes
Masrouri, S., Hasanpour, A., Ebrahimi, N., & Hadaegh, F. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02968-2 · Cited by 3
Effects of Glucose Fluctuations on Electrocardiogram Readings and the Development of Ventricular Arrhythmia in Diabetic Rats
Wu, L., Li, F., Wang, C., Dang, S., Xiao, F., Zhang, Z., Zhang, J., Zhang, Y., Lu, C.-Y., Liu, Y., et al. (2022) · Cardiology Discovery · doi:10.1097/cd9.0000000000000055 · Cited by 2
Insulin Treatment of Diabetes Mellitus-Tight vs. Conventional Control
Emanuele, N., & Reaven, P. D. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-13177-6_34 · Cited by 2
Self-citation
Modeling blood vessel dynamics: Effects of glucose variations on HUVECs in a hollow fiber bioreactor under laminar shear stress
Ładyżyński, P., Ciechanowska, A., Sabalińska, S., Foltyński, P., Wencel, A., Wojciechowski, C., Pluta, K. D., & Chwojnowski, A. (2024) · Journal of Applied Biomedicine · doi:10.1016/j.bbe.2024.08.004 · Cited by 2
Long-term glycemic variability and the risk of cardiovascular diseases in type 2 diabetic patients: Effect of hypothetical interventions using parametric g-formula in a population-based historical cohort study
Maajani, K., Nasli‐Esfahani, E., Fahimfar, N., Sheidaei, A., Mansournia, M. A., & Yazdani, K. (2025) · PLoS ONE · doi:10.1371/journal.pone.0319975 · Cited by 2

Authors: Zhou, J. J., Schwenke, D. C., Bahn, G., & Reaven, P.
Affiliations: University of Arizona (US)
Carl T. Hayden Veterans Affairs Medical Center (US)
Edward Hines, Jr. VA Hospital (US)
Corresponding author: Zhou, Jin J.
ORCID: Zhou, Jin J.
Schwenke, Dawn C.
Reaven, Peter
Venue: Diabetes Care
Publisher: American Diabetes Association
Published: 2018-08-06
Volume: 41
Issue: 10
Pages: 2187-2194
ISSN: 0149-5992 (ISSN-L)
1935-5548
DOI: 10.2337/dc18-0548
PMC: PMC6150432
OpenAlex: W2887193038
Cited by: 131
References: 37
Citations by year: 2026: 4 · 2025: 14 · 2024: 9 · 2023: 24 · 2022: 16 · 2021: 23 · 2020: 24 · 2019: 17
FWCI: 12.73
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.diabetesjournals.org/content/license (vor, 45 d)
Locations: Diabetes Care (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (R01-067690, 5R01-094775, K01-DK-106116)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: glycemic variability, cardiovascular disease, type 2 diabetes, fasting blood glucose, HbA1c, tight glycemic control, coefficient of variation, average real variability, hypoglycemia
MeSH terms: Aged, Blood Glucose, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Fasting, Female, Glycated Hemoglobin, Humans, Male, Middle Aged, Risk Factors, Veterans

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Glycemic Variation and Cardiovascular Risk in the Veterans Affairs Diabetes Trial

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks